Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoproliferative Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03121677
What this trial is testing

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT02420795
What this trial is testing

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more
M.D. Anderson Cancer Center 16
Not applicableUnknownNCT04048395
What this trial is testing

Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea

Who this might be right for
Follicular Lymphoma
Samsung Medical Center 80
Not applicableStudy completedNCT02692339
What this trial is testing

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 22
Not applicableUnknownNCT02039895
What this trial is testing

Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Far Eastern Memorial Hospital 10
Early research (Phase 1)Not Yet RecruitingNCT07660939
What this trial is testing

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Who this might be right for
Plasma Cell DisordersMultiple Myeloma (MM)
Peking University First Hospital 50
Early research (Phase 1)Study completedNCT01791595
What this trial is testing

A Phase I Trial of AZD3965 in Patients With Advanced Cancer

Who this might be right for
Adult Solid TumorDiffuse Large B Cell LymphomaBurkitt Lymphoma
Cancer Research UK 53
Testing effectiveness (Phase 2)Study completedNCT03192202
What this trial is testing

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Ahmed Sawas 18
Early research (Phase 1)UnknownNCT04004637
What this trial is testing

CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia

Who this might be right for
T-lymphoblastic LymphomaNK/T Cell LymphomaAcute Lymphocytic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Ended earlyNCT00369629
What this trial is testing

Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 14
Large-scale testing (Phase 3)Study completedNCT00022737
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionRecurrent Childhood Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 220
Not applicableStudy completedNCT06032806
What this trial is testing

Effects of 8 Weeks Moderate and High Intensity Training on Hemoglobin Levels of Female Students

Who this might be right for
Moderate and High Intensity Training and Hemoglobin Levels
Riphah International University 28
Not applicableUnknownNCT06335277
What this trial is testing

Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology

Who this might be right for
LeukemiaLeukemia, ChronicLeukemia, Acute+2 more
European Institute of Oncology 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing

Phase I Trial of GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Not applicableStudy completedNCT01815788
What this trial is testing

Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid

Who this might be right for
Mild and Moderate Presbycusis
Centre Hospitalier Universitaire de Nice 31
Testing effectiveness (Phase 2)Study completedNCT00364286
What this trial is testing

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 17
Not applicableStudy completedNCT01006070
What this trial is testing

Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine

Who this might be right for
Multiple Myeloma
University of California, San Francisco 50
Early research (Phase 1)Active Not RecruitingNCT05784441
What this trial is testing

JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

Who this might be right for
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC 21
Testing effectiveness (Phase 2)Study completedNCT00251394
What this trial is testing

Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Dana-Farber Cancer Institute 30
Next Page